Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 1:08 PM EST

Emergent BioSolutions (EBS) EV to EBIT (2011 - 2026)

Updated

Emergent BioSolutions' (EBS) EV to EBIT stood at 4.44 in Q1 2026, up 1.4% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) EV to EBIT (2011 - 2026) Analysis & Trends

On a TTM basis, Emergent BioSolutions' EV to EBIT came in at -7.39 as of Mar 31, 2026; for FY2025, it came in at 4.38.

  • Across earlier years, EV to EBIT came in at 4.84 in FY2021 (-48.6%).
  • The Q1 2026 figure is the highest quarterly EV to EBIT since Q3 2022.
  • Per Business Quant, the preceding three quarters came in at 4.38 (Q4 2025), 1.85 (Q3 2025) and 0.71 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.44
Dec 31, 2025 4.38
Sep 30, 2025 1.85
Jun 30, 2025 0.71
Sep 30, 2022 4.69
Jun 30, 2022 6.90
Mar 31, 2022 6.38
Dec 31, 2021 4.84
Sep 30, 2021 7.31
Jun 30, 2021 7.01
Mar 31, 2021 8.24
Dec 31, 2020 9.54
Sep 30, 2020 19.97
Jun 30, 2020 14.89
Mar 31, 2020 21.90
Dec 31, 2019 22.97
Sep 30, 2019 53.86
Mar 31, 2019 34.21
Dec 31, 2018 32.55
Sep 30, 2018 22.51
API Access

Emergent BioSolutions EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=EBS&period=max&api_key=YOUR_API_KEY